Papers by Wylie Vale
Page 3 · newest first
- Potent and Long-Acting Corticotropin Releasing Factor (CRF) Receptor 2 Selective Peptide Competitive AntagonistsJournal of Medicinal Chemistry · 2002
- Corticotropin-releasing factor receptor 2 is a tonic suppressor of vascularizationProceedings of the National Academy of Sciences · 2002
- Phosphorylation regulation of the interaction between Smad7 and activin type I receptorFEBS Letters · 2002
- The Distribution of Betaglycan Protein and mRNA in Rat Brain, Pituitary, and Gonads: Implications for a Role for Betaglycan in Inhibin-Mediated Reproductive FunctionsEndocrinology · 2002
- Effect of Adenovirus-Mediated Overexpression of Follistatin and Extracellular Domain of Activin Receptor Type II on Gonadotropin Secretion in Vitro and in VivoEndocrinology · 2002
- Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor ExpressionJournal of Neuroscience · 2002
- Mice Deficient for Both Corticotropin-Releasing Factor Receptor 1 (CRFR1) and CRFR2 Have an Impaired Stress Response and Display Sexually Dichotomous Anxiety-Like BehaviorJournal of Neuroscience · 2002
- Ingestive responses to administration of stress hormones in baboonsAJP Regulatory Integrative and Comparative Physiology · 2002
- Expression, Purification, and Characterization of a Soluble Form of the First Extracellular Domain of the Human Type 1 Corticotropin Releasing Factor ReceptorJournal of Biological Chemistry · 2001
- Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptorProceedings of the National Academy of Sciences · 2001
- Actions of Activins, Inhibins and Follistatins: Implications in Anterior Pituitary FunctionClinical and Experimental Pharmacology and Physiology · 2001
- Mice That Lack Corticotropin‐Releasing Factor (CRF) Receptors Type 1 Show a Blunted ACTH Response to Acute Alcohol Despite Up‐Regulated Constitutive Hypothalamic CRF Gene ExpressionAlcoholism Clinical and Experimental Research · 2001
- Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptorsProceedings of the National Academy of Sciences · 2001
- Constitutive activation of tethered-peptide/ corticotropin-releasing factor receptor chimerasProceedings of the National Academy of Sciences · 2000
- Characterization of the N-Linked Glycan of Recombinantly-Expressed Corticotropin Releasing Factor Binding ProteinEuropean Journal of Mass Spectrometry · 2000
- Regulation of Corticotropin-Releasing Factor Receptor Type 2β Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines*Endocrinology · 2000
- Dissociation of Locomotor Activation and Suppression of Food Intake Induced by CRF in CRFR1-Deficient MiceEndocrinology · 2000
- Identification of a Binding Site on the Type II Activin Receptor for Activin and InhibinJournal of Biological Chemistry · 2000
- Urocortin Expression in Rat Brain: Evidence Against a Pervasive Relationship of Urocortin-Containing Projections With Targets Bearing Type 2 CRF ReceptorsThe Journal of Comparative Neurology · 1999
- Urocortin Messenger Ribonucleic Acid: Tissue Distribution in the Rat and Regulation in Thymus by Lipopolysaccharide and Glucocorticoids1Endocrinology · 1999
- Ultrastructural localization of the corticotropin-releasing factor-binding protein in rat brain and pituitaryThe Journal of Comparative Neurology · 1999
- Corticotropin Releasing Factor Receptors and Their Ligand FamilyAnnals of the New York Academy of Sciences · 1999
- Constrained Corticotropin Releasing Factor Antagonists (Astressin Analogues) with Long Duration of Action in the RatJournal of Medicinal Chemistry · 1999
- Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor II1Endocrinology · 1999
- Corticotropin Releasing Factor (CRF) Agonists with Reduced Amide Bonds and Ser⁷SubstitutionsJournal of Medicinal Chemistry · 1999
- CRF Type I Receptor-Deficient Mice Exhibit a Pronounced Pituitary-Adrenal Response to Local InflammationEndocrinology · 1999
- Urocortin Is Not a Significant Regulator of Intermittent Electrofootshock-Induced Adrenocorticotropin Secretion in the Intact Male Rat**This work was supported by NIH Grant DK-26741 and The Foundation for Research.Endocrinology · 1999
- Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor SignalingMolecular Endocrinology · 1999
- Constrained Corticotropin-Releasing Factor (CRF) Agonists and Antagonists withi−(i+3) Glu-Xaa- d Xbb-Lys BridgesJournal of Medicinal Chemistry · 1998
- Interleukin-1β Regulates Pituitary Follistatin and Inhibin/Activin βB mRNA Levels and Attenuates FSH Secretion in Response to Activin-AEndocrinology · 1998
- Minimal-Size, Constrained Corticotropin-Releasing Factor Agonists withi−(i+3) Glu−Lys and Lys−Glu BridgesJournal of Medicinal Chemistry · 1998
- Expression and Secretion of Inhibin and Activin in Normal and Neoplastic Uterine Tissues. High Levels of Serum Activin A in Women with Endometrial and Cervical Carcinoma1The Journal of Clinical Endocrinology & Metabolism · 1998
- Displacement of insulin-like growth factors from their binding proteins as a potential treatment for strokeProceedings of the National Academy of Sciences · 1998
- The First Extracellular Domain of Corticotropin Releasing Factor-R1 Contains Major Binding Determinants for Urocortin and Astressin*Endocrinology · 1998
- Human Growth Hormone-Releasing Hormone hGHRH(1−29)-NH2: Systematic Structure−Activity Relationship StudiesJournal of Medicinal Chemistry · 1998
- Smad8 mediates the signaling of the receptor serine kinaseProceedings of the National Academy of Sciences · 1997
- Constrained Corticotropin-Releasing Factor Antagonists withi-(i+ 3) Glu−Lys BridgesJournal of Medicinal Chemistry · 1997
- Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune systemThe Journal of Immunology · 1997
- Activin and Inhibin Have Antagonistic Effects on Ligand-Dependent Heteromerization of the Type I and Type II Activin Receptors and Human Erythroid DifferentiationMolecular and Cellular Biology · 1997
- Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizureBrain Research · 1997
- Corticotropin-Releasing Factor (CRF) Family of Ligands and Their ReceptorsThe Endocrinologist · 1997
- Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawalProceedings of the National Academy of Sciences · 1996
- Regulation of transforming growth factor β- and activin-induced transcription by mammalian Mad proteinsProceedings of the National Academy of Sciences · 1996
- Dose relationship between GnRH antagonists and pituitary suppressionHuman Reproduction · 1996
- Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.Endocrinology · 1996
- Human placenta and fetal membranes express human urocortin mRNA and peptide.The Journal of Clinical Endocrinology & Metabolism · 1996
- Appetite-Suppressing Effects of Urocortin, a CRF-Related NeuropeptideScience · 1996
- Cloning and characterization of human urocortin.Endocrinology · 1996
- Hybridization histochemical and immunohistochemical localization of inhibin/activin subunits and messenger ribonucleic acids in the rat brainThe Journal of Comparative Neurology · 1996
- Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures.Endocrinology · 1996